Stay updated on Cabozantinib for PN in NF1: Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib for PN in NF1: Clinical Trial page.
Latest updates to the Cabozantinib for PN in NF1: Clinical Trial page
- Check4 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4; no visible changes to the study page.SummaryDifference0.0%
- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedLocations section added listing all sites by state and state-specific location headers removed, consolidating site information in one place. Revision updated to v3.3.3.SummaryDifference1%
- Check54 days agoChange DetectedPubMed-related notes in the Publications and Deletions sections were updated, adding Revision: v3.3.2 for additions and Revision: v3.2.0 for deletions.SummaryDifference0.1%
- Check61 days agoChange DetectedA notice about a lapse in government funding and potential delays was removed from the page; core trial details such as eligibility, endpoints, and locations remain unchanged.SummaryDifference0.3%
- Check75 days agoChange DetectedThe changes are limited to formatting and wording updates on the Study Details page, with no changes to study design, endpoints, eligibility criteria, or enrollment figures. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%
- Check104 days agoChange DetectedNew operating-status notice and version update to v3.2.0; previous v3.1.0 version tag removed.SummaryDifference2%
Stay in the know with updates to Cabozantinib for PN in NF1: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib for PN in NF1: Clinical Trial page.